Healthcare -
Biotechnology - NASDAQ - US
$ 15.49
-7.91 %
$ 475 M
Market Cap
-2.56
P/E
ANAB - GROSS PROFIT
Gross Profit ANAB - AnaptysBio, Inc.
14.8 M
LAST VALUE
55.51%
2 YEAR CAGR
18.01%
5 YEAR CAGR
20.45%
10 YEAR CAGR